The effect of aclidinium bromide on daily respiratory symptoms of COPD, measured using the Evaluating Respiratory Symptoms in COPD (E-RS: COPD) diary: pooled analysis of two 6-month Phase III studies. [electronic resource]
Producer: 20171201Description: 61 p. digitalISSN:- 1465-993X
- Administration, Inhalation
- Aged
- Bronchodilator Agents -- administration & dosage
- Clinical Trials, Phase III as Topic
- Disease Progression
- Drug Administration Schedule
- Drug Therapy, Combination
- Female
- Forced Expiratory Volume
- Humans
- Lung -- drug effects
- Male
- Middle Aged
- Multicenter Studies as Topic
- Muscarinic Antagonists -- administration & dosage
- Pulmonary Disease, Chronic Obstructive -- diagnosis
- Randomized Controlled Trials as Topic
- Recovery of Function
- Respiration -- drug effects
- Severity of Illness Index
- Time Factors
- Treatment Outcome
- Tropanes -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.